Goldman Sachs’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.6M | Buy |
|
|||||
|
2025
Q2 | $6.82M | Buy |
|
|||||
|
2025
Q1 | $6.33M | Sell |
|
|||||
|
2024
Q4 | $10.6M | Sell |
|
|||||
|
2024
Q3 | $25M | Buy |
|
|||||
|
2024
Q2 | $21.5M | Sell |
|
|||||
|
2024
Q1 | $19.4M | Sell |
|
|||||
|
2023
Q4 | $20.8M | Sell |
|
|||||
|
2023
Q3 | $19.1M | Buy |
|
|||||
|
2023
Q2 | $27.2M | Sell |
|
|||||
|
2023
Q1 | $32.1M | Sell |
|
|||||
|
2022
Q4 | $20.2M | Sell |
|
|||||
|
2022
Q3 | $31M | Buy |
|
|||||
|
2022
Q2 | $23.7M | Sell |
|
|||||
|
2022
Q1 | $39.6M | Sell |
|
|||||
|
2021
Q4 | $51M | Sell |
|
|||||
|
2021
Q3 | $68.8M | Sell |
|
|||||
|
2021
Q2 | $67.7M | Buy |
|
|||||
|
2021
Q1 | $40.7M | Sell |
|
|||||
|
2020
Q4 | $29.6M | Buy |
|
|||||
|
2020
Q3 | $12.8M | Sell |
|
|||||
|
2020
Q2 | $13M | Buy |
|
|||||
|
2020
Q1 | $8.02M | Buy |
|
|||||
|
2019
Q4 | $14.5M | Sell |
|
|||||
|
2019
Q3 | $17.1M | Sell |
|
|||||
|
2019
Q2 | $19.8M | Sell |
|
|||||
|
2019
Q1 | $25.6M | Buy |
|
|||||
|
2018
Q4 | $15.8M | Sell |
|
|||||
|
2018
Q3 | $33.3M | Sell |
|
|||||
|
2018
Q2 | $40M | Sell |
|
|||||
|
2018
Q1 | $46.6M | Buy |
|
|||||
|
2017
Q4 | $28.8M | Sell |
|
|||||
|
2017
Q3 | $32.3M | Sell |
|
|||||
|
2017
Q2 | $25.9M | Buy |
|
|||||
|
2017
Q1 | $18.2M | Buy |
|
|||||
|
2016
Q4 | $14.5M | Sell |
|
|||||
|
2016
Q3 | $29.7M | Buy |
|
|||||
|
2016
Q2 | $30.3M | Buy |
|
|||||
|
2016
Q1 | $8.05M | Buy |
|
|||||
|
2015
Q4 | $5.76M | Buy |
|
|||||
|
2015
Q3 | $3.75M | Sell |
|
|||||
|
2015
Q2 | $5.15M | Sell |
|
|||||
|
2015
Q1 | $12.1M | Sell |
|
|||||
|
2014
Q4 | $17.2M | Buy |
|
|||||
|
2014
Q3 | $10.1M | Sell |
|
|||||
|
2014
Q2 | $15.3M | Buy |
|
|||||
|
2014
Q1 | $9.58M | Sell |
|
|||||
|
2013
Q4 | $14M | Sell |
|
|||||
|
2013
Q3 | $40M | Sell |
|
|||||
|
2013
Q2 | $48.5M | Buy |
|